Drugs / prostatic acid phosphatase-sargramostim fusion protein
prostatic acid phosphatase-sargramostim fusion protein
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00027599 | Dec 2001 → Jul 2007 | prostate cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prostatic acid phosphatase-sargramostim fusion protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00027599 ↗ |
| Modality | Protein / enzyme biologic | “prostatic acid phosphatase-sargramostim fusion protein” NCT00027599 ↗ |